老鼠林 personal page - To The Moon

老鼠林

老鼠林

No personal profile

1219Follow

141Followers

5Topic

0Badge

04-27 22:05

$NVIDIA(NVDA)$ win go go go...

04-20

$NVIDIA(NVDA)$ go go go

04-13

$NVIDIA(NVDA)$ go go go..and win more

04-06

$NVIDIA(NVDA)$ go go go nice

03-30

$NVIDIA(NVDA)$ good..good

03-23

$NVIDIA(NVDA)$ jia you go go

03-16

$NVIDIA(NVDA)$ go go go

03-10

$NVIDIA(NVDA)$ good

03-10

$Broadcom(AVGO)$ good...!!

03-09

$Broadcom(AVGO)$ sad

03-03

$NVIDIA(NVDA)$ good n great

03-03

$NVIDIA(NVDA)$ nice

02-20

$NVIDIA(NVDA)$ go go go

02-20

$NVIDIA(NVDA)$ go go go

2024-05-06

$Halliburton(HAL)$

2023-10-25

Hope have a good income soon!

2023-04-13

Nice

The 3 Best Growth Stocks to Buy-and-Hold Through 2030

2023-04-13

O👍

2 Nasdaq Growth Stocks That Are Screaming Buys in April

2023-03-21

ok

@twizzy:$GameStop(GME)$ $AMC Entertainment(AMC)$ With Tesla's surge today and Bitcoin's rally, it can be seen that speculative sentiment may recover and usher in a new wave. Keep an eye on the direction of the broader market after tomorrow's meeting, and if it is a dovish speech, I believe that the broader market will usher in a wave of rebound, and the hunger and thirst for long-term backlogs will definitely follow up speculative individual stocks, including cryptocurrencies. Therefore, the US stock market pays attention to GME，AMC etc.

2023-03-12

ok

Sorry, the original content has been removed

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3570321847771869","uuid":"3570321847771869","gmtCreate":1607229303441,"gmtModify":1613732199319,"name":"老鼠林","pinyin":"lsllaoshulin","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":141,"headSize":1219,"tweetSize":403,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":5,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.28%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.35%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":429130457256088,"gmtCreate":1745791517278,"gmtModify":1745791521335,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> win go go go...","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> win go go go...","text":"$NVIDIA(NVDA)$ win go go go...","images":[{"img":"https://community-static.tradeup.com/news/d4b0e8e1bace74baaed1bcb0d61cedb7","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/429130457256088","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":426575910920512,"gmtCreate":1745164973290,"gmtModify":1745164978244,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","text":"$NVIDIA(NVDA)$ go go go","images":[{"img":"https://community-static.tradeup.com/news/76228ffdfd6a157e20953f3ca9c105a8","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/426575910920512","isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":424075574972776,"gmtCreate":1744560081610,"gmtModify":1744597935000,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go..and win more","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go..and win more","text":"$NVIDIA(NVDA)$ go go go..and win more","images":[{"img":"https://community-static.tradeup.com/news/db15ce2bcf82d4e24b0801e03e5fbf25","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/424075574972776","isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":421669176213720,"gmtCreate":1743977223737,"gmtModify":1743977228379,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go nice","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go nice","text":"$NVIDIA(NVDA)$ go go go nice","images":[{"img":"https://community-static.tradeup.com/news/74e641f1ce791deca9e2da3675ca0943","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/421669176213720","isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":419252420522176,"gmtCreate":1743355806897,"gmtModify":1743355811322,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> good..good","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> good..good","text":"$NVIDIA(NVDA)$ good..good","images":[{"img":"https://community-static.tradeup.com/news/ad8497aefe19a04949eada1ef6c1c692","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/419252420522176","isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":416807523258888,"gmtCreate":1742767531548,"gmtModify":1742767535953,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> jia you go go","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> jia you go go","text":"$NVIDIA(NVDA)$ jia you go go","images":[{"img":"https://community-static.tradeup.com/news/18d628429eb0ce7c4b3b687a379202ec","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/416807523258888","isVote":1,"tweetType":1,"viewCount":367,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":414414555697224,"gmtCreate":1742162687436,"gmtModify":1742162691174,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","text":"$NVIDIA(NVDA)$ go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/414414555697224","isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":411963161117168,"gmtCreate":1741597236046,"gmtModify":1741597240326,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> good","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> good","text":"$NVIDIA(NVDA)$ good","images":[{"img":"https://community-static.tradeup.com/news/0d4cb4b278fb0f41b82ff503c52eb20e","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/411963161117168","isVote":1,"tweetType":1,"viewCount":190,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":412004771271080,"gmtCreate":1741577157421,"gmtModify":1741577162210,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AVGO\">$Broadcom(AVGO)$ </a> good...!!","listText":"<a href=\"https://ttm.financial/S/AVGO\">$Broadcom(AVGO)$ </a> good...!!","text":"$Broadcom(AVGO)$ good...!!","images":[{"img":"https://community-static.tradeup.com/news/14292d5d7f2860c534d7771bc7442af9","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/412004771271080","isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":411751031476896,"gmtCreate":1741557829708,"gmtModify":1741557834664,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AVGO\">$Broadcom(AVGO)$ </a> sad","listText":"<a href=\"https://ttm.financial/S/AVGO\">$Broadcom(AVGO)$ </a> sad","text":"$Broadcom(AVGO)$ sad","images":[{"img":"https://community-static.tradeup.com/news/e41fdd67b603e6aad50999d417644acb","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/411751031476896","isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":409619065660072,"gmtCreate":1741014191152,"gmtModify":1741014197930,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> good n great","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> good n great","text":"$NVIDIA(NVDA)$ good n great","images":[{"img":"https://community-static.tradeup.com/news/2d913217e20719ef912db6dca3f9894d","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/409619065660072","isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":409619185144288,"gmtCreate":1741014134675,"gmtModify":1741014141557,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> nice","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> nice","text":"$NVIDIA(NVDA)$ nice","images":[{"img":"https://community-static.tradeup.com/news/ffb3f03d26a1090495756d44b02d7b54","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/409619185144288","isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":405666906985096,"gmtCreate":1740067550388,"gmtModify":1740067553538,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","text":"$NVIDIA(NVDA)$ go go go","images":[{"img":"https://community-static.tradeup.com/news/24cdff2436a1f154fe25b737700e39f0","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/405666906985096","isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":405666722054792,"gmtCreate":1740067505239,"gmtModify":1740067510366,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> go go go","text":"$NVIDIA(NVDA)$ go go go","images":[{"img":"https://community-static.tradeup.com/news/7ddcf288a96b607a21a81fa967b6844b","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/405666722054792","isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":302968589582552,"gmtCreate":1715002550336,"gmtModify":1715002554163,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HAL\">$Halliburton(HAL)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/HAL\">$Halliburton(HAL)$ </a>&nbsp;","text":"$Halliburton(HAL)$","images":[{"img":"https://community-static.tradeup.com/news/b61d0ddc0cf12e1711eb6cae2102fd61","width":"882","height":"1608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/302968589582552","isVote":1,"tweetType":1,"viewCount":1131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":234329933738232,"gmtCreate":1698249862759,"gmtModify":1698249866736,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"Hope have a good income soon!","listText":"Hope have a good income soon!","text":"Hope have a good income soon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/234329933738232","isVote":1,"tweetType":1,"viewCount":902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9945138082,"gmtCreate":1681399433047,"gmtModify":1681399436814,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9945138082","repostId":"2327839281","repostType":2,"repost":{"id":"2327839281","kind":"highlight","pubTimestamp":1681393438,"share":"https://ttm.financial/m/news/2327839281?lang=&edition=full_marsco","pubTime":"2023-04-13 21:43","market":"us","language":"en","title":"The 3 Best Growth Stocks to Buy-and-Hold Through 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2327839281","media":"InvestorPlace","summary":"The Trade Desk (TTD): This company was profitable before Covid-19 and should remain profitable going","content":"<html><head></head><body><ul><li><p><strong>The Trade Desk</strong> (<strong><u>TTD</u></strong>): This company was profitable before Covid-19 and should remain profitable going forward.</p></li><li><p><strong><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></strong> (<strong><u>SNOW</u></strong>): After a big selloff, Snowflake finally has a more reasonable valuation while generating powerful growth.</p></li><li><p><strong>DigitalOcean</strong> (<strong><u>DOCN</u></strong>): They have made the bottom line a clear focus, making it a rare growth stock to own in the current environment.</p></li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1cd188c662e207e04955c8a6c1519735\" tg-width=\"768\" tg-height=\"432\"/></p><p>Source: Freedom365day / Shutterstock.com</p><p>There are a handful of stocks that are showing their true potential right now. However, because of the bear market we saw in 2022, many remain well off their highs. For those who know where to look, there are still some solid growth stocks to buy and hold for the years ahead.</p><p>Growth stocks tend to do best with a loose fiscal monetary policy from global central banks. More specifically, they tend to do best when the Federal Reserve’s interest rates are low. With rates currently at multi-year highs, and with the Fed remaining hawkish, it’s clearly a tough time for growth-stock investors.</p><p>There are businesses that continue to hum along quite nicely even if the stocks aren’t getting carried higher by a bull market. I want to look at three growth stocks to buy and hold that are profitable and have a promising future.</p><h2>The Trade Desk (TTD)</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84c2d928e8088714815b90f711b0a266\" tg-width=\"300\" tg-height=\"169\"/></p><p>Source: Shutterstock</p><p><strong>The Trade Desk</strong> (NASDAQ:<strong>TTD</strong>) is and has been a top-tier growth stock. Hitting an all-time high in November 2021, it was one of the last stocks in tech to wave the white flag amid the heavy selling pressure felt industry-wide. While the stock did eventually succumb to the selling pressure, it’s likely only an opportunity for long-term patient investors.</p><p>Co-founder and CEO Jeff Green has built a remarkable company that continues to slug it out with the heavyweights in online advertising. Unlike <strong>Meta</strong> (NASDAQ:<strong>META</strong>), <strong>Alphabet</strong> (NASDAQ:<strong><u>GOOGL</u></strong>, NASDAQ:<strong><u>GOOG</u></strong>) and other giants, The Trade Desk can operate in China. That’s an enormous market that many of their U.S. competitors don’t have access to.</p><p>While a recession would certainly slow digital ad purchases, and thus The Trade Desk’s business, the company continues to hum along nicely.</p><p>Analysts expect 20% to 24% annual revenue growth for the next four fiscal years. The Trade Desk was profitable before Covid-19 and has remained profitable after. While estimates call for just 7% earnings growth this year, expectations accelerate dramatically in 2024.</p><h2>Snowflake (SNOW)</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c76568eb7d71483e5887515cb6d03ce3\" tg-width=\"300\" tg-height=\"169\"/></p><p>Source: Blackboard / Shutterstock</p><p><strong>Snowflake</strong> (NYSE:<strong>SNOW</strong>) went public in September 2020 to a lot of fanfare. In the days leading up to the IPO, the valuation soared. It didn’t help that Warren Buffett’s <strong>Berkshire Hathaway</strong> (NYSE:<strong><u>BRK-A</u></strong>, NYSE:<strong><u>BRK-B</u></strong>) and <strong>Salesforce</strong> (NYSE:<strong>CRM</strong>) were getting involved via investments, or that we were in a raging bull market.</p><p>While the stock eventually opened at $245 and soared to almost $430 in the weeks to come, it has cooled off dramatically. Snowflake stock has since shed about two-thirds of its peak value and currently trades near $140 a share.</p><p>It’s not cheap based on traditional metrics, shares trade at roughly 15 times this year’s revenue forecasts and at about 22 times its trailing 12 months of sales.  However, it’s a lot cheaper than it was a year or two ago when Snowflake was trading well over 100 times its trailing revenue.</p><p>Forecasts call for strong revenue growth to continue, including 40% this year and 37% next year. In the following two years, long-term estimates sit above 30%. That’s a lot of growth if it comes to fruition and would take the company’s sales figure from $2.06 billion in fiscal year 2023 to more than $7 billion in fiscal year 2027.</p><h2>DigitalOcean (DOCN)</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b78b6dbdbf77b7e503f711797b057564\" tg-width=\"300\" tg-height=\"169\"/></p><p>Source: Shutterstock</p><p>When it comes to market capitalization, <strong>DigitalOcean</strong> (NYSE:<strong>DOCN</strong>) is 8.5 times smaller than The Trade Desk and almost 13 times smaller than Snowflake. In the context of these three stocks, it’s definitely the smallest fish in the pond, or should I say ocean, but that doesn’t mean the company doesn’t belong.</p><p>DigitalOcean is forecast to generate annual revenue growth in the low-20% range for the next several years. However, estimates call for roughly 75% earnings growth this year and almost 25% growth in 2024.</p><p>If achieved, DigitalOcean will generate $1.65 a share in non-GAAP earnings. While the company is not yet GAAP profitable, it’s clear that management’s focus is on the bottom line. That was evident when the company provided guidance for the year, blowing away consensus estimates.</p></body></html>","source":"investorplace","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The 3 Best Growth Stocks to Buy-and-Hold Through 2030</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe 3 Best Growth Stocks to Buy-and-Hold Through 2030\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-13 21:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2023/04/the-3-best-growth-stocks-to-buy-and-hold-through-2030/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Trade Desk (TTD): This company was profitable before Covid-19 and should remain profitable going forward.Snowflake (SNOW): After a big selloff, Snowflake finally has a more reasonable valuation ...</p>\n\n<a href=\"https://investorplace.com/2023/04/the-3-best-growth-stocks-to-buy-and-hold-through-2030/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0234572021.USD":"高盛美国核心股票组合Acc","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0109392836.USD":"富兰克林科技股A","BK4559":"巴菲特持仓","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","BK4588":"碎股","BK4579":"人工智能","BK4587":"ChatGPT概念","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","DOCN":"DigitalOcean Holdings, Inc.","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4573":"虚拟现实","LU0861579265.USD":"联博低波幅策略股票基金A","BK4566":"资本集团","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0276348264.USD":"THREADNEEDLE (LUX) GLOBAL DYNAMIC REAL RETURN\"AUP\" (USD) INC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","BK4581":"高盛持仓","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","TTD":"Trade Desk Inc.","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4514":"搜索引擎","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4528":"SaaS概念","BK4023":"应用软件","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","BK4532":"文艺复兴科技持仓","LU0957808578.USD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"ZU\" (USD) ACC","SG9999014914.USD":"UNITED GLOBAL QUALITY GROWTH (USDHDG) INC","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","BK4554":"元宇宙及AR概念","SNOW":"Snowflake","BK4553":"喜马拉雅资本持仓","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","LU0312595415.SGD":"Schroder ISF Global Climate Change Equity A Acc SGD","BK4585":"ETF&股票定投概念","LU0056508442.USD":"贝莱德世界科技基金A2","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc"},"source_url":"https://investorplace.com/2023/04/the-3-best-growth-stocks-to-buy-and-hold-through-2030/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2327839281","content_text":"The Trade Desk (TTD): This company was profitable before Covid-19 and should remain profitable going forward.Snowflake (SNOW): After a big selloff, Snowflake finally has a more reasonable valuation while generating powerful growth.DigitalOcean (DOCN): They have made the bottom line a clear focus, making it a rare growth stock to own in the current environment.Source: Freedom365day / Shutterstock.comThere are a handful of stocks that are showing their true potential right now. However, because of the bear market we saw in 2022, many remain well off their highs. For those who know where to look, there are still some solid growth stocks to buy and hold for the years ahead.Growth stocks tend to do best with a loose fiscal monetary policy from global central banks. More specifically, they tend to do best when the Federal Reserve’s interest rates are low. With rates currently at multi-year highs, and with the Fed remaining hawkish, it’s clearly a tough time for growth-stock investors.There are businesses that continue to hum along quite nicely even if the stocks aren’t getting carried higher by a bull market. I want to look at three growth stocks to buy and hold that are profitable and have a promising future.The Trade Desk (TTD)Source: ShutterstockThe Trade Desk (NASDAQ:TTD) is and has been a top-tier growth stock. Hitting an all-time high in November 2021, it was one of the last stocks in tech to wave the white flag amid the heavy selling pressure felt industry-wide. While the stock did eventually succumb to the selling pressure, it’s likely only an opportunity for long-term patient investors.Co-founder and CEO Jeff Green has built a remarkable company that continues to slug it out with the heavyweights in online advertising. Unlike Meta (NASDAQ:META), Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG) and other giants, The Trade Desk can operate in China. That’s an enormous market that many of their U.S. competitors don’t have access to.While a recession would certainly slow digital ad purchases, and thus The Trade Desk’s business, the company continues to hum along nicely.Analysts expect 20% to 24% annual revenue growth for the next four fiscal years. The Trade Desk was profitable before Covid-19 and has remained profitable after. While estimates call for just 7% earnings growth this year, expectations accelerate dramatically in 2024.Snowflake (SNOW)Source: Blackboard / ShutterstockSnowflake (NYSE:SNOW) went public in September 2020 to a lot of fanfare. In the days leading up to the IPO, the valuation soared. It didn’t help that Warren Buffett’s Berkshire Hathaway (NYSE:BRK-A, NYSE:BRK-B) and Salesforce (NYSE:CRM) were getting involved via investments, or that we were in a raging bull market.While the stock eventually opened at $245 and soared to almost $430 in the weeks to come, it has cooled off dramatically. Snowflake stock has since shed about two-thirds of its peak value and currently trades near $140 a share.It’s not cheap based on traditional metrics, shares trade at roughly 15 times this year’s revenue forecasts and at about 22 times its trailing 12 months of sales.  However, it’s a lot cheaper than it was a year or two ago when Snowflake was trading well over 100 times its trailing revenue.Forecasts call for strong revenue growth to continue, including 40% this year and 37% next year. In the following two years, long-term estimates sit above 30%. That’s a lot of growth if it comes to fruition and would take the company’s sales figure from $2.06 billion in fiscal year 2023 to more than $7 billion in fiscal year 2027.DigitalOcean (DOCN)Source: ShutterstockWhen it comes to market capitalization, DigitalOcean (NYSE:DOCN) is 8.5 times smaller than The Trade Desk and almost 13 times smaller than Snowflake. In the context of these three stocks, it’s definitely the smallest fish in the pond, or should I say ocean, but that doesn’t mean the company doesn’t belong.DigitalOcean is forecast to generate annual revenue growth in the low-20% range for the next several years. However, estimates call for roughly 75% earnings growth this year and almost 25% growth in 2024.If achieved, DigitalOcean will generate $1.65 a share in non-GAAP earnings. While the company is not yet GAAP profitable, it’s clear that management’s focus is on the bottom line. That was evident when the company provided guidance for the year, blowing away consensus estimates.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9945131498,"gmtCreate":1681399419314,"gmtModify":1681399423458,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"O👍&nbsp;","listText":"O👍&nbsp;","text":"O👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":16,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9945131498","repostId":"2327623153","repostType":2,"repost":{"id":"2327623153","kind":"highlight","pubTimestamp":1681397217,"share":"https://ttm.financial/m/news/2327623153?lang=&edition=full_marsco","pubTime":"2023-04-13 22:46","market":"us","language":"en","title":"2 Nasdaq Growth Stocks That Are Screaming Buys in April","url":"https://stock-news.laohu8.com/highlight/detail?id=2327623153","media":"Motley Fool","summary":"Massive drivers of fresh earnings are drawing closer, and risks are declining.","content":"<html><head></head><body><p>Among the growth-heavy stocks of the <strong>Nasdaq Composite</strong>, a few companies stand out as being especially promising. At the moment, two enterprising biopharma players -- <strong>Vertex Pharmaceuticals </strong>(VRTX) and <strong>CRISPR Therapeutics</strong> (CRSP) -- are particularly appealing. That&#39;s thanks to their combination of relative security and near-term catalysts.</p><p>What&#39;s more, their fates are intertwined, so an investment in one could benefit from the positive developments of the other. Here&#39;s why it&#39;s worth buying at least one of the pair.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5b91dbbd7aa3f44290c5cb8cae0dbf2\" tg-width=\"700\" tg-height=\"466\"/></p><p>Image source: Getty Images.</p><h2>1. Vertex Pharmaceuticals</h2><p>Vertex is likely on the verge of realizing its strategic plan to diversify its portfolio of medicines.</p><p>If you&#39;re not familiar with Vertex, its claim to fame over the last decade has been its cystic fibrosis (CF) therapies. Sales of its four medicines for CF led to net income of more than $3.2 billion in 2022. Given that CF is a rare genetic pulmonary disease that only affects 88,000 people in the Western world, and that the company already treats all but around 25,000 of them, its mastery of the market is hard to overstate.</p><p>It&#39;s reasonable to expect its CF business to continue yielding significant income for the foreseeable future as the people living with CF will continue to need its medicines. And soon, if all goes well, it&#39;s set to advance into two markets outside CF for the first time, which should pave the way for further top- and bottom-line growth.</p><p>In collaboration with CRISPR, Vertex announced on April 3 that it had submitted its regulatory approval packet to the Food and Drug Administration (FDA) for its gene therapy, called exa-cel, which is designed to treat a pair of rare genetic diseases called beta thalassemia and sickle cell disease (SCD). If regulators find the application to meets their standards, they could approve the drug in as few as eight months. </p><p>The market for SCD medicines is expected to reach $8.7 billion by 2029, according to Fortune Business Insights, and the market for beta thalassemia therapies could be as large as $823 million by 2030 per a report by Spherical Insights. Capturing a share of both of those markets with exa-cel would position Vertex to potentially grow its 2022 revenue of $8.9 billion significantly more by the end of the decade. And that&#39;s before taking the prospects of sales from any of its other late-stage pipeline programs into account.</p><p>Of course, there&#39;s always the chance of failure in securing approvals and running clinical trials. But given Vertex&#39;s dominance in the CF market, this de-risks the potential consequences of falling short by providing a strong base of revenue -- making this a good time to buy the stock now.</p><h2>2. CRISPR Therapeutics</h2><p>CRISPR Therapeutics stands to benefit even more than Vertex does from getting exa-cel approved, assuming that happens. </p><p>Unlike Vertex, CRISPR doesn&#39;t have any products on the market, which means that exa-cel will be its first chance to generate revenue. Wall Street analysts are guesstimating that if exa-cel gets the go-ahead from the FDA, the company could bring in $297 million in 2024. That would be an enormous rate of revenue growth, to say the least. More importantly, it should position the biotech to self-fund its further pipeline development without the help of debt or collaborators like Vertex. </p><p>On that note, CRISPR has a trio of clinical-stage oncology programs that could ultimately treat lymphoma, among other cancers. It&#39;s also working on a pair of clinical-stage gene therapies to treat diabetes. There&#39;s no guarantee it&#39;ll get any of those programs out the door, even if it wins with exa-cel. The point for investors to appreciate is that in early 2024 it could become self-sustaining, which will dramatically increase its stock&#39;s price. </p><p>Typically, biotech stocks like CRISPR would be quite risky even when they&#39;re likely to commercialize a new medicine. But with more than $1.8 billion in cash and equivalents on hand, and 2022 operating expenses of only $563 million, even a setback with exa-cel shouldn&#39;t bring CRISPR down by much. And if it succeeds, it&#39;ll be adding to its cash hoard -- giving it greater room to maneuver and potentially even acquire promising smaller competitors. And that&#39;s just one more reason it&#39;s an outstanding buy.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Nasdaq Growth Stocks That Are Screaming Buys in April</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Nasdaq Growth Stocks That Are Screaming Buys in April\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-13 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Among the growth-heavy stocks of the Nasdaq Composite, a few companies stand out as being especially promising. At the moment, two enterprising biopharma players -- Vertex Pharmaceuticals (VRTX) and ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4556":"基因编辑","BK4585":"ETF&股票定投概念","BK4093":"化肥与农用药剂","LU1861558580.USD":"日兴方舟颠覆性创新基金B","VERX":"Vertex, Inc.","BK4139":"生物科技","BK4588":"碎股","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4023":"应用软件","CRSP":"CRISPR Therapeutics AG"},"source_url":"https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2327623153","content_text":"Among the growth-heavy stocks of the Nasdaq Composite, a few companies stand out as being especially promising. At the moment, two enterprising biopharma players -- Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics (CRSP) -- are particularly appealing. That's thanks to their combination of relative security and near-term catalysts.What's more, their fates are intertwined, so an investment in one could benefit from the positive developments of the other. Here's why it's worth buying at least one of the pair.Image source: Getty Images.1. Vertex PharmaceuticalsVertex is likely on the verge of realizing its strategic plan to diversify its portfolio of medicines.If you're not familiar with Vertex, its claim to fame over the last decade has been its cystic fibrosis (CF) therapies. Sales of its four medicines for CF led to net income of more than $3.2 billion in 2022. Given that CF is a rare genetic pulmonary disease that only affects 88,000 people in the Western world, and that the company already treats all but around 25,000 of them, its mastery of the market is hard to overstate.It's reasonable to expect its CF business to continue yielding significant income for the foreseeable future as the people living with CF will continue to need its medicines. And soon, if all goes well, it's set to advance into two markets outside CF for the first time, which should pave the way for further top- and bottom-line growth.In collaboration with CRISPR, Vertex announced on April 3 that it had submitted its regulatory approval packet to the Food and Drug Administration (FDA) for its gene therapy, called exa-cel, which is designed to treat a pair of rare genetic diseases called beta thalassemia and sickle cell disease (SCD). If regulators find the application to meets their standards, they could approve the drug in as few as eight months. The market for SCD medicines is expected to reach $8.7 billion by 2029, according to Fortune Business Insights, and the market for beta thalassemia therapies could be as large as $823 million by 2030 per a report by Spherical Insights. Capturing a share of both of those markets with exa-cel would position Vertex to potentially grow its 2022 revenue of $8.9 billion significantly more by the end of the decade. And that's before taking the prospects of sales from any of its other late-stage pipeline programs into account.Of course, there's always the chance of failure in securing approvals and running clinical trials. But given Vertex's dominance in the CF market, this de-risks the potential consequences of falling short by providing a strong base of revenue -- making this a good time to buy the stock now.2. CRISPR TherapeuticsCRISPR Therapeutics stands to benefit even more than Vertex does from getting exa-cel approved, assuming that happens. Unlike Vertex, CRISPR doesn't have any products on the market, which means that exa-cel will be its first chance to generate revenue. Wall Street analysts are guesstimating that if exa-cel gets the go-ahead from the FDA, the company could bring in $297 million in 2024. That would be an enormous rate of revenue growth, to say the least. More importantly, it should position the biotech to self-fund its further pipeline development without the help of debt or collaborators like Vertex. On that note, CRISPR has a trio of clinical-stage oncology programs that could ultimately treat lymphoma, among other cancers. It's also working on a pair of clinical-stage gene therapies to treat diabetes. There's no guarantee it'll get any of those programs out the door, even if it wins with exa-cel. The point for investors to appreciate is that in early 2024 it could become self-sustaining, which will dramatically increase its stock's price. Typically, biotech stocks like CRISPR would be quite risky even when they're likely to commercialize a new medicine. But with more than $1.8 billion in cash and equivalents on hand, and 2022 operating expenses of only $563 million, even a setback with exa-cel shouldn't bring CRISPR down by much. And if it succeeds, it'll be adding to its cash hoard -- giving it greater room to maneuver and potentially even acquire promising smaller competitors. And that's just one more reason it's an outstanding buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943652795,"gmtCreate":1679436090417,"gmtModify":1679436094117,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943652795","repostId":"9943658231","repostType":1,"repost":{"id":9943658231,"gmtCreate":1679427943124,"gmtModify":1679434588913,"author":{"id":"3479274727372317","authorId":"3479274727372317","name":"twizzy","avatar":"https://static.tigerbbs.com/3580435900283ddd3c40a46b3de0adbc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3479274727372317","authorIdStr":"3479274727372317"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/GME\">$GameStop(GME)$</a> <a href=\"https://ttm.financial/S/AMC\">$AMC Entertainment(AMC)$</a> &nbsp;With Tesla's surge today and Bitcoin's rally, it can be seen that speculative sentiment may recover and usher in a new wave. Keep an eye on the direction of the broader market after tomorrow's meeting, and if it is a dovish speech, I believe that the broader market will usher in a wave of rebound, and the hunger and thirst for long-term backlogs will definitely follow up speculative individual stocks, including cryptocurrencies. Therefore, the US stock market pays attention to GME，AMC etc.","listText":"<a href=\"https://ttm.financial/S/GME\">$GameStop(GME)$</a> <a href=\"https://ttm.financial/S/AMC\">$AMC Entertainment(AMC)$</a> &nbsp;With Tesla's surge today and Bitcoin's rally, it can be seen that speculative sentiment may recover and usher in a new wave. Keep an eye on the direction of the broader market after tomorrow's meeting, and if it is a dovish speech, I believe that the broader market will usher in a wave of rebound, and the hunger and thirst for long-term backlogs will definitely follow up speculative individual stocks, including cryptocurrencies. Therefore, the US stock market pays attention to GME，AMC etc.","text":"$GameStop(GME)$ $AMC Entertainment(AMC)$ With Tesla's surge today and Bitcoin's rally, it can be seen that speculative sentiment may recover and usher in a new wave. Keep an eye on the direction of the broader market after tomorrow's meeting, and if it is a dovish speech, I believe that the broader market will usher in a wave of rebound, and the hunger and thirst for long-term backlogs will definitely follow up speculative individual stocks, including cryptocurrencies. Therefore, the US stock market pays attention to GME，AMC etc.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943658231","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9949666172,"gmtCreate":1678604578596,"gmtModify":1678604581951,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949666172","repostId":"627424382","repostType":1,"isVote":1,"tweetType":1,"viewCount":1165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9945131498,"gmtCreate":1681399419314,"gmtModify":1681399423458,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"O👍&nbsp;","listText":"O👍&nbsp;","text":"O👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":16,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9945131498","repostId":"2327623153","repostType":2,"repost":{"id":"2327623153","kind":"highlight","pubTimestamp":1681397217,"share":"https://ttm.financial/m/news/2327623153?lang=&edition=full_marsco","pubTime":"2023-04-13 22:46","market":"us","language":"en","title":"2 Nasdaq Growth Stocks That Are Screaming Buys in April","url":"https://stock-news.laohu8.com/highlight/detail?id=2327623153","media":"Motley Fool","summary":"Massive drivers of fresh earnings are drawing closer, and risks are declining.","content":"<html><head></head><body><p>Among the growth-heavy stocks of the <strong>Nasdaq Composite</strong>, a few companies stand out as being especially promising. At the moment, two enterprising biopharma players -- <strong>Vertex Pharmaceuticals </strong>(VRTX) and <strong>CRISPR Therapeutics</strong> (CRSP) -- are particularly appealing. That&#39;s thanks to their combination of relative security and near-term catalysts.</p><p>What&#39;s more, their fates are intertwined, so an investment in one could benefit from the positive developments of the other. Here&#39;s why it&#39;s worth buying at least one of the pair.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5b91dbbd7aa3f44290c5cb8cae0dbf2\" tg-width=\"700\" tg-height=\"466\"/></p><p>Image source: Getty Images.</p><h2>1. Vertex Pharmaceuticals</h2><p>Vertex is likely on the verge of realizing its strategic plan to diversify its portfolio of medicines.</p><p>If you&#39;re not familiar with Vertex, its claim to fame over the last decade has been its cystic fibrosis (CF) therapies. Sales of its four medicines for CF led to net income of more than $3.2 billion in 2022. Given that CF is a rare genetic pulmonary disease that only affects 88,000 people in the Western world, and that the company already treats all but around 25,000 of them, its mastery of the market is hard to overstate.</p><p>It&#39;s reasonable to expect its CF business to continue yielding significant income for the foreseeable future as the people living with CF will continue to need its medicines. And soon, if all goes well, it&#39;s set to advance into two markets outside CF for the first time, which should pave the way for further top- and bottom-line growth.</p><p>In collaboration with CRISPR, Vertex announced on April 3 that it had submitted its regulatory approval packet to the Food and Drug Administration (FDA) for its gene therapy, called exa-cel, which is designed to treat a pair of rare genetic diseases called beta thalassemia and sickle cell disease (SCD). If regulators find the application to meets their standards, they could approve the drug in as few as eight months. </p><p>The market for SCD medicines is expected to reach $8.7 billion by 2029, according to Fortune Business Insights, and the market for beta thalassemia therapies could be as large as $823 million by 2030 per a report by Spherical Insights. Capturing a share of both of those markets with exa-cel would position Vertex to potentially grow its 2022 revenue of $8.9 billion significantly more by the end of the decade. And that&#39;s before taking the prospects of sales from any of its other late-stage pipeline programs into account.</p><p>Of course, there&#39;s always the chance of failure in securing approvals and running clinical trials. But given Vertex&#39;s dominance in the CF market, this de-risks the potential consequences of falling short by providing a strong base of revenue -- making this a good time to buy the stock now.</p><h2>2. CRISPR Therapeutics</h2><p>CRISPR Therapeutics stands to benefit even more than Vertex does from getting exa-cel approved, assuming that happens. </p><p>Unlike Vertex, CRISPR doesn&#39;t have any products on the market, which means that exa-cel will be its first chance to generate revenue. Wall Street analysts are guesstimating that if exa-cel gets the go-ahead from the FDA, the company could bring in $297 million in 2024. That would be an enormous rate of revenue growth, to say the least. More importantly, it should position the biotech to self-fund its further pipeline development without the help of debt or collaborators like Vertex. </p><p>On that note, CRISPR has a trio of clinical-stage oncology programs that could ultimately treat lymphoma, among other cancers. It&#39;s also working on a pair of clinical-stage gene therapies to treat diabetes. There&#39;s no guarantee it&#39;ll get any of those programs out the door, even if it wins with exa-cel. The point for investors to appreciate is that in early 2024 it could become self-sustaining, which will dramatically increase its stock&#39;s price. </p><p>Typically, biotech stocks like CRISPR would be quite risky even when they&#39;re likely to commercialize a new medicine. But with more than $1.8 billion in cash and equivalents on hand, and 2022 operating expenses of only $563 million, even a setback with exa-cel shouldn&#39;t bring CRISPR down by much. And if it succeeds, it&#39;ll be adding to its cash hoard -- giving it greater room to maneuver and potentially even acquire promising smaller competitors. And that&#39;s just one more reason it&#39;s an outstanding buy.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Nasdaq Growth Stocks That Are Screaming Buys in April</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Nasdaq Growth Stocks That Are Screaming Buys in April\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-13 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Among the growth-heavy stocks of the Nasdaq Composite, a few companies stand out as being especially promising. At the moment, two enterprising biopharma players -- Vertex Pharmaceuticals (VRTX) and ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4556":"基因编辑","BK4585":"ETF&股票定投概念","BK4093":"化肥与农用药剂","LU1861558580.USD":"日兴方舟颠覆性创新基金B","VERX":"Vertex, Inc.","BK4139":"生物科技","BK4588":"碎股","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4023":"应用软件","CRSP":"CRISPR Therapeutics AG"},"source_url":"https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2327623153","content_text":"Among the growth-heavy stocks of the Nasdaq Composite, a few companies stand out as being especially promising. At the moment, two enterprising biopharma players -- Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics (CRSP) -- are particularly appealing. That's thanks to their combination of relative security and near-term catalysts.What's more, their fates are intertwined, so an investment in one could benefit from the positive developments of the other. Here's why it's worth buying at least one of the pair.Image source: Getty Images.1. Vertex PharmaceuticalsVertex is likely on the verge of realizing its strategic plan to diversify its portfolio of medicines.If you're not familiar with Vertex, its claim to fame over the last decade has been its cystic fibrosis (CF) therapies. Sales of its four medicines for CF led to net income of more than $3.2 billion in 2022. Given that CF is a rare genetic pulmonary disease that only affects 88,000 people in the Western world, and that the company already treats all but around 25,000 of them, its mastery of the market is hard to overstate.It's reasonable to expect its CF business to continue yielding significant income for the foreseeable future as the people living with CF will continue to need its medicines. And soon, if all goes well, it's set to advance into two markets outside CF for the first time, which should pave the way for further top- and bottom-line growth.In collaboration with CRISPR, Vertex announced on April 3 that it had submitted its regulatory approval packet to the Food and Drug Administration (FDA) for its gene therapy, called exa-cel, which is designed to treat a pair of rare genetic diseases called beta thalassemia and sickle cell disease (SCD). If regulators find the application to meets their standards, they could approve the drug in as few as eight months. The market for SCD medicines is expected to reach $8.7 billion by 2029, according to Fortune Business Insights, and the market for beta thalassemia therapies could be as large as $823 million by 2030 per a report by Spherical Insights. Capturing a share of both of those markets with exa-cel would position Vertex to potentially grow its 2022 revenue of $8.9 billion significantly more by the end of the decade. And that's before taking the prospects of sales from any of its other late-stage pipeline programs into account.Of course, there's always the chance of failure in securing approvals and running clinical trials. But given Vertex's dominance in the CF market, this de-risks the potential consequences of falling short by providing a strong base of revenue -- making this a good time to buy the stock now.2. CRISPR TherapeuticsCRISPR Therapeutics stands to benefit even more than Vertex does from getting exa-cel approved, assuming that happens. Unlike Vertex, CRISPR doesn't have any products on the market, which means that exa-cel will be its first chance to generate revenue. Wall Street analysts are guesstimating that if exa-cel gets the go-ahead from the FDA, the company could bring in $297 million in 2024. That would be an enormous rate of revenue growth, to say the least. More importantly, it should position the biotech to self-fund its further pipeline development without the help of debt or collaborators like Vertex. On that note, CRISPR has a trio of clinical-stage oncology programs that could ultimately treat lymphoma, among other cancers. It's also working on a pair of clinical-stage gene therapies to treat diabetes. There's no guarantee it'll get any of those programs out the door, even if it wins with exa-cel. The point for investors to appreciate is that in early 2024 it could become self-sustaining, which will dramatically increase its stock's price. Typically, biotech stocks like CRISPR would be quite risky even when they're likely to commercialize a new medicine. But with more than $1.8 billion in cash and equivalents on hand, and 2022 operating expenses of only $563 million, even a setback with exa-cel shouldn't bring CRISPR down by much. And if it succeeds, it'll be adding to its cash hoard -- giving it greater room to maneuver and potentially even acquire promising smaller competitors. And that's just one more reason it's an outstanding buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881779929,"gmtCreate":1631409869161,"gmtModify":1676530542030,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"buy!","listText":"buy!","text":"buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/881779929","repostId":"1101906502","repostType":2,"repost":{"id":"1101906502","kind":"news","pubTimestamp":1631407634,"share":"https://ttm.financial/m/news/1101906502?lang=&edition=full_marsco","pubTime":"2021-09-12 08:47","market":"us","language":"en","title":"Buy or Sell Apple Stock Ahead of iPhone Event?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101906502","media":"TheStreet","summary":"Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.Shares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.On Sept. 14, the company will hold a virtual event to introduce the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.However, Apple remains in the news for other reas","content":"<p>Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.</p>\n<p>Shares of Apple&nbsp;Report&nbsp;fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.</p>\n<p>On Sept. 14, the company will&nbsp;hold a virtual event to introduce&nbsp;the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.</p>\n<p>However, Apple remains in the news for other reasons, too.</p>\n<p>After hitting new highs earlier this week, the stock declined Friday after news of a court ruling&nbsp;in its case with Epic Games.</p>\n<p>That’s alongside a report that was published by well-known Morgan Stanley analyst Katy Huberty, who made the case that Apple stock&nbsp;is “compelling” ahead of its upcoming event.</p>\n<p>Like I said, it’s a lot of information for investors to digest. Let’s take a look at how the charts are setting up.</p>\n<p><b>Trading Apple Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd94f6dcfc32af44a4ae542425f3c92f\" tg-width=\"700\" tg-height=\"429\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p>\n<p>Each time Apple has reported earnings this year, it has resulted in a selloff. Unfortunately, those selloffs would come right as the stock was at or near all-time highs. Those events are marked on the chart with blue arrows.</p>\n<p>It was even more frustrating that Apple&nbsp;blew out analysts’ expectations each time, yet the stock sold off anyway.</p>\n<p>However, rather than a massive dip following the most recent report, the stock only pulled back to the $145 area, near the prior high. It also held the 21-day moving average as support.</p>\n<p>The stock has since pushed up through $150 and earlier this week, hit new all-time highs.</p>\n<p>For now, we’re getting a dip back down to the key $150 area and the 21-day moving average. Aggressive bulls can buy this dip ahead of the company’s event on Tuesday.</p>\n<p>If we break Friday’s low, investors may consider stopping out of the trade and buying on a potentially larger dip down to the 50-day moving average or the $145 area.</p>\n<p>Below $145 may put the $138 level and the 200-day moving average in play.</p>\n<p>Should Apple trade up through the all-time high at $157.26, the 161.8% extension is in play up near $160. Above that mark could put the $172 to $175 zone on the table, depending on how investors react to the event.</p>\n<p>For what it’s worth, September is by far Apple’s worst-performing month, up just three of the last 11 years for the month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy or Sell Apple Stock Ahead of iPhone Event?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy or Sell Apple Stock Ahead of iPhone Event?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.\nShares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as ...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-ahead-of-iphone13-event","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101906502","content_text":"Apple stock was under pressure on Friday, with its iPhone event just days away. Here's how to trade the stock from here.\nShares of Apple Report fell $5.10, or 3.31%, to end at $148.97 Friday, as investors digested recent news and prepared for the iPhone event next week.\nOn Sept. 14, the company will hold a virtual event to introduce the new device. Dubbed “California Streaming,” it’s expected that Apple will introduce its new iPhone and Apple Watch.\nHowever, Apple remains in the news for other reasons, too.\nAfter hitting new highs earlier this week, the stock declined Friday after news of a court ruling in its case with Epic Games.\nThat’s alongside a report that was published by well-known Morgan Stanley analyst Katy Huberty, who made the case that Apple stock is “compelling” ahead of its upcoming event.\nLike I said, it’s a lot of information for investors to digest. Let’s take a look at how the charts are setting up.\nTrading Apple Stock\nDaily chart of Apple stock.\nEach time Apple has reported earnings this year, it has resulted in a selloff. Unfortunately, those selloffs would come right as the stock was at or near all-time highs. Those events are marked on the chart with blue arrows.\nIt was even more frustrating that Apple blew out analysts’ expectations each time, yet the stock sold off anyway.\nHowever, rather than a massive dip following the most recent report, the stock only pulled back to the $145 area, near the prior high. It also held the 21-day moving average as support.\nThe stock has since pushed up through $150 and earlier this week, hit new all-time highs.\nFor now, we’re getting a dip back down to the key $150 area and the 21-day moving average. Aggressive bulls can buy this dip ahead of the company’s event on Tuesday.\nIf we break Friday’s low, investors may consider stopping out of the trade and buying on a potentially larger dip down to the 50-day moving average or the $145 area.\nBelow $145 may put the $138 level and the 200-day moving average in play.\nShould Apple trade up through the all-time high at $157.26, the 161.8% extension is in play up near $160. Above that mark could put the $172 to $175 zone on the table, depending on how investors react to the event.\nFor what it’s worth, September is by far Apple’s worst-performing month, up just three of the last 11 years for the month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322078902,"gmtCreate":1615761596206,"gmtModify":1704786093916,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"should i buy the stock now?&nbsp;","listText":"should i buy the stock now?&nbsp;","text":"should i buy the stock now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/322078902","repostId":"2119999169","repostType":2,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573453631833460","authorId":"3573453631833460","name":"jiraiya自来也","avatar":"https://static.tigerbbs.com/c5b5826a50d61b77ced4fbb0c8220737","crmLevel":2,"crmLevelSwitch":0,"idStr":"3573453631833460","authorIdStr":"3573453631833460"},"content":"portfolio sizing","text":"portfolio sizing","html":"portfolio sizing"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":130200831,"gmtCreate":1621550110623,"gmtModify":1704359317400,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/130200831","repostId":"2136010949","repostType":4,"isVote":1,"tweetType":1,"viewCount":490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340632003,"gmtCreate":1617400721302,"gmtModify":1704699378541,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/340632003","repostId":"2124875875","repostType":4,"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576743360399762","authorId":"3576743360399762","name":"PooYen","avatar":"https://static.tigerbbs.com/90f2bad6620330727869f3a5a51a046a","crmLevel":2,"crmLevelSwitch":0,"idStr":"3576743360399762","authorIdStr":"3576743360399762"},"content":"Please like, comment and response. Thanks. [smile] [smile] [smile]","text":"Please like, comment and response. Thanks. [smile] [smile] [smile]","html":"Please like, comment and response. Thanks. [smile] [smile] [smile]"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":429130457256088,"gmtCreate":1745791517278,"gmtModify":1745791521335,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> win go go go...","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a> win go go go...","text":"$NVIDIA(NVDA)$ win go go go...","images":[{"img":"https://community-static.tradeup.com/news/d4b0e8e1bace74baaed1bcb0d61cedb7","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/429130457256088","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805311294,"gmtCreate":1627860631418,"gmtModify":1703496561228,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805311294","repostId":"1170689665","repostType":4,"isVote":1,"tweetType":1,"viewCount":845,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179538871,"gmtCreate":1626560707293,"gmtModify":1703761637823,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/179538871","repostId":"2151350423","repostType":4,"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180355928,"gmtCreate":1623191231164,"gmtModify":1704197834760,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/180355928","repostId":"1150047118","repostType":4,"isVote":1,"tweetType":1,"viewCount":165,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581818742728168","authorId":"3581818742728168","name":"CWen","avatar":"https://static.tigerbbs.com/31b0269cbebdce24b628856129a8ab15","crmLevel":2,"crmLevelSwitch":0,"idStr":"3581818742728168","authorIdStr":"3581818742728168"},"content":"Comment back pls","text":"Comment back pls","html":"Comment back pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":194686913,"gmtCreate":1621377513032,"gmtModify":1704356490337,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"up and up!","listText":"up and up!","text":"up and up!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/194686913","repostId":"2135161248","repostType":4,"isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":196706480,"gmtCreate":1621117467140,"gmtModify":1704352923687,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"why? haha","listText":"why? haha","text":"why? haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/196706480","repostId":"1163454382","repostType":4,"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329686141,"gmtCreate":1615243072583,"gmtModify":1704779961210,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"the dip is too much","listText":"the dip is too much","text":"the dip is too much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/329686141","repostId":"1130305981","repostType":4,"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3568244403436818","authorId":"3568244403436818","name":"AGS","avatar":"https://static.tigerbbs.com/b729576e3822c0c56b578d5c4ca11862","crmLevel":4,"crmLevelSwitch":0,"idStr":"3568244403436818","authorIdStr":"3568244403436818"},"content":"The dip gets deeper ??‍♀️","text":"The dip gets deeper ??‍♀️","html":"The dip gets deeper ??‍♀️"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9952725924,"gmtCreate":1675028923968,"gmtModify":1676538970284,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a><v-v data-views=\"1\"></v-v>go pls","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a><v-v data-views=\"1\"></v-v>go pls","text":"$Apple(AAPL)$ go pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9952725924","isVote":1,"tweetType":1,"viewCount":428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9083101453,"gmtCreate":1650076191236,"gmtModify":1676534642273,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083101453","repostId":"2227638600","repostType":4,"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":192632966,"gmtCreate":1621204908855,"gmtModify":1704353751472,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"drop at the end of day","listText":"drop at the end of day","text":"drop at the end of day","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/192632966","repostId":"1163454382","repostType":4,"isVote":1,"tweetType":1,"viewCount":443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108942012,"gmtCreate":1619997126736,"gmtModify":1704336984616,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"pls increase more&nbsp;","listText":"pls increase more&nbsp;","text":"pls increase more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/108942012","repostId":"2132595758","repostType":2,"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109751734,"gmtCreate":1619734987828,"gmtModify":1704271421489,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"so good..big earning","listText":"so good..big earning","text":"so good..big earning","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/109751734","repostId":"1188611661","repostType":4,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3563169547090112","authorId":"3563169547090112","name":"钱手Moneyhand","avatar":"https://static.tigerbbs.com/2f43148f25e4815df83b732941dfe71c","crmLevel":1,"crmLevelSwitch":0,"idStr":"3563169547090112","authorIdStr":"3563169547090112"},"content":"Reply to my comments pls","text":"Reply to my comments pls","html":"Reply to my comments pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957297935,"gmtCreate":1677257655428,"gmtModify":1677257658437,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a>go go go","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$&nbsp;</a>go go go","text":"$Apple(AAPL)$ go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9957297935","isVote":1,"tweetType":1,"viewCount":1634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9928708020,"gmtCreate":1671399984360,"gmtModify":1676538528854,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AMD\">$Advanced Micro Devices(AMD)$&nbsp;</a><v-v data-views=\"1\"></v-v>go","listText":"<a href=\"https://ttm.financial/S/AMD\">$Advanced Micro Devices(AMD)$&nbsp;</a><v-v data-views=\"1\"></v-v>go","text":"$Advanced Micro Devices(AMD)$ go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9928708020","isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9933370987,"gmtCreate":1662247641550,"gmtModify":1676537021780,"author":{"id":"3570321847771869","authorId":"3570321847771869","name":"老鼠林","avatar":"https://static.tigerbbs.com/fad7ed311b00b26bb7fef488f5212d02","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570321847771869","authorIdStr":"3570321847771869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a><v-v data-views=\"0\"></v-v>sad","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a><v-v data-views=\"0\"></v-v>sad","text":"$Apple(AAPL)$sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9933370987","isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}